Pamukcuoglu, M. et al. 2021. The infection rate in new diagnosis and relapsed/refractory multiple myeloma patients who had bortezomib-based chemotherapy and relationship between development of infection and lymphocyte/monocyte ratio. The European Research Journal. 7, 6 (Nov. 2021), 541–549. DOI:https://doi.org/10.18621/eurj.855510.